In Vitro Phenotypic Susceptibility of HIV-2 Clinical Isolates to CCR5 Inhibitors

HIV-2 is naturally resistant to nonnucleoside reverse transcriptase inhibitors, to a fusion inhibitor, and to some of the protease inhibitors. Maraviroc is the first drug of the new anti-CCR5 drug class and is effective only on CCR5-tropic (R5) HIV-1. No previous studies concerning HIV-2 susceptibil...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Visseaux, Benoit, Charpentier, Charlotte, Hurtado-Nedelec, Margarita, Storto, Alexandre, Antoine, Romain, Peytavin, Gilles, Damond, Florence, Matheron, Sophie, Brun-Vézinet, Françoise, Descamps, Diane
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3256042/
https://ncbi.nlm.nih.gov/pubmed/22064539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05313-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados